Moon Ho Son

Discovery of DA-1229: A potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

Heung Jae Kim, Woo Young Kwak, Jong Pil Min et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 52 citations · Full text

Diabetes Management, Biochemistry, Medicine +7

A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis

Jae Min Cho, Hye Won Jang, Hwanju Cheon et al. · Diabetes Research and Clinical Practice · 2010 · 50 citations

Diabetes Management, Engineering, Medicine +8

Potentiation of cadmium-induced cytotoxicity by sulfur amino acid deprivation through activation of extracellular signal-regulated kinase1/2 (ERK1/2) in conjunction with p38 kinase or c-jun N-terminal kinase (JNK)

Moon Ho Son, Keon Wook Kang, Chang Ho Lee et al. · Biochemical Pharmacology · 2001 · 42 citations

Signal Transduction, Biochemistry, Medicine +15

PAR-5359, a well-balanced PPARα/γ dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo

Mi-Kyung Kim, Yu Na Chae, Moon Ho Son et al. · European Journal of Pharmacology · 2008 · 32 citations

Metabolic Syndrome, Biochemistry, Medicine +8

PAR-1622 is a selective peroxisome proliferator-activated receptor γ partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention

Mi-Kyung Kim, Yu Na Chae, Hae Sun Kim et al. · Archives of Pharmacal Research · 2009 · 22 citations

Fluid Retention, Diabetes Management, Preserved Antidiabetic Efficacy +7